YUHSpace: Dept. of Internal Medicine (내과학교실)

YUHSpace

BROWSE

YUHSpace1. College of Medicine (의과대학)Dept. of Internal Medicine (내과학교실)

Dept. of Internal Medicine (내과학교실)

Researcher List

Keyword Cloud

Journal Categories

Highly Cited Articles

Trastuzumab in combination with chemotherapy versus chemotherapy alone f...

Yung-Jue Bang ; Eric Van Cutsem ; Andrea Feyereislova ; Hyun C Chung ; Lin Sh... LANCET, Vol.376(9742) : 687-697, 2010

Osimertinib in Untreated EGFR-Mutated Advanced Non–Small-Cell Lung Cancer

Jean-Charles Soria ; Yuichiro Ohe ; Johan Vansteenkiste ; Thanyanan Reungwetw... NEW ENGLAND JOURNAL OF MEDICINE, Vol.378(2) : 113-125, 2018

Durvalumab after Chemoradiotherapy in Stage III Non-Small-Cell Lung Cancer

S.J. Antonia ; A. Villegas ; D. Daniel ; D. Vicente ; S. Murakami ; R. Hui ; ... NEW ENGLAND JOURNAL OF MEDICINE, Vol.377(20) : 1919-1929, 2017

This table browses all dspace content
Issue Date	Title	Journal Title
2022	Coronary CTA With AI-QCT Interpretation: Comparison With Myocardial Perfusion Imaging for Detection of Obstructive Stenosis Using Invasive Angiography as Reference Standard	AMERICAN JOURNAL OF ROENTGENOLOGY
2022	Non-Inferior Efficacy of Tenofovir Disoproxil to Tenofovir Disoproxil Fumarate in Virologically Suppressed Chronic Hepatitis B Patients	DRUG DESIGN DEVELOPMENT AND THERAPY
2022	The HOPE Asia network 2022 up-date consensus statement on morning hypertension management	JOURNAL OF CLINICAL HYPERTENSION
2022	Effect of Dapagliflozin in Combination with Lobeglitazone and Metformin in Korean Patients with Type 2 Diabetes in Real-World Clinical Practice	YONSEI MEDICAL JOURNAL
2022	House dust mite-induced Akt-ERK1/2-C/EBP beta pathway triggers CCL20-mediated inflammation and epithelial-mesenchymal transition for airway remodeling	FASEB JOURNAL
2022	Factors Affecting Selection of a Dialysis Modality in Elderly Patients With Chronic Kidney Disease: A Prospective Cohort Study in Korea	FRONTIERS IN MEDICINE
2022	Incremental prognostic value of triglyceride glucose index additional to coronary artery calcium score in asymptomatic low-risk population	CARDIOVASCULAR DIABETOLOGY
2022	Non-High-Density Lipoprotein Cholesterol and Cardiovascular Outcomes in Chronic Kidney Disease: Results from KNOW-CKD Study	NUTRIENTS
2022	A phase I-II multicenter, open-label, dose-escalation study to evaluate the safety, pharmacokinetics, pharmacodynamics, and antitumor activity of ABN401 in patients with advanced solid tumors and dose-expansion in patients with non-small cell lung cancer harboring c-MET dysregulation	ANNALS OF ONCOLOGY
2022	Vascular Pathology and Impact of Stent Eccentricity for Stent Restenosis in Femoropopliteal Endovascular Therapy	JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY
2022	Phase III study of canakinumab (CAN) as adjuvant therapy in patients (pts) with completely resected non-small cell lung cancer (NSCLC)	ANNALS OF ONCOLOGY
2022	Datopotamab deruxtecan (Dato-DXd), a TROP2 antibody-drug conjugate, vs investigators’ choice of chemotherapy (ICC) in previously-treated, inoperable or metastatic hormone-receptor (HR) positive, HER2-negative (HR+/HER2–) breast cancer: TROPION-Breast01	ANNALS OF ONCOLOGY
2022	Biological insights into systemic lupus erythematosus through an immune cell-specific transcriptome-wide association study	ANNALS OF THE RHEUMATIC DISEASES
2022	2022 Consensus statement on the management of familial hypercholesterolemia in Korea	KOREAN JOURNAL OF INTERNAL MEDICINE
2022	Updates on conventional therapies for inflammatory bowel diseases: 5-aminosalicylates, corticosteroids, immunomodulators, and anti-TNF-α	KOREAN JOURNAL OF INTERNAL MEDICINE
2022	Hyperprogressive disease during PD-1 blockade in patients with advanced gastric cancer	EUROPEAN JOURNAL OF CANCER
2022	Delirium screening in critically ill patients: validation of the Korean version of the 4 A’s Test	EUROPEAN RESPIRATORY JOURNAL
2022	Effects of screening and treatment improvement on colon cancer survival over 20 years in Korea	ANNALS OF ONCOLOGY
2022	Elacestrant vs fulvestrant or aromatase inhibitor (AI) in phase III trial evaluating elacestrant, an oral selective estrogen receptor degrader (SERD), vs standard of care (SOC) endocrine monotherapy for ER+/HER2- advanced/metastatic breast cancer (mBC): Subgroup analysis from EMERALD	ANNALS OF ONCOLOGY
2022	Cardiovascular risks associated with calcium supplementation in patients with osteoporosis: a nationwide cohort study	EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY